Comparisons of Long-Term Survival and Safety of Haploidentical Hematopoietic Stem Cell Transplantation After CAR-T Cell Therapy or Chemotherapy in Pediatric Patients With First Relapse of B-Cell Acute Lymphoblastic Leukemia Based on MRD-Guided Treatment

Measurable residual disease (MRD) positivity before haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is an independent prognostic factor in determining outcomes in patients with B-cell acute lymphoblastic leukemia (ALL). In this study, we conducted a parallel comparison of the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Guanhua, Cheng, Yifei, Zuo, Yingxi, Chang, Yingjun, Suo, Pan, Jia, Yueping, Lu, Aidong, Wang, Yu, Jiao, Shunchang, Zhang, Longji, Sun, Yuqian, Yan, Chenhua, Xu, Lanping, Zhang, Xiaohui, Liu, Kaiyan, Zhang, Leping, Huang, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207442/
https://www.ncbi.nlm.nih.gov/pubmed/35734165
http://dx.doi.org/10.3389/fimmu.2022.915590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207442/
https://www.ncbi.nlm.nih.gov/pubmed/35734165
http://dx.doi.org/10.3389/fimmu.2022.915590

Ejemplares similares